Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von DropStone 

Verastem Inc. diskutieren

Verastem Inc.

WKN: A3EHM3 / Symbol: VSTM / Name: Verastem / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

12,10 €
-0,82 %

Buy Verastem Inc.

Einschätzung Buy
Rendite (%) 97,49 %
Kursziel 2,84
Veränderung
Endet am 15.03.24

Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $3.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 97,49 %
Kursziel 2,84
Veränderung
Endet am 15.03.24

Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 1186,55 %
Kursziel 33,13
Veränderung
Endet am 15.06.24

Verastem, Inc. (NASDAQ: VSTM) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $36.00 price target on the stock, up previously from $24.00.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 1186,55 %
Kursziel 33,18
Veränderung
Endet am 29.08.24

Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $36.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 43,42 %
Kursziel 19,90
Veränderung
Endet am 27.09.24

Verastem, Inc. (NASDAQ: VSTM) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 119,82 %
Kursziel 31,32
Veränderung
Endet am 15.11.24

Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Truist Financial Co. from $39.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 83,19 %
Kursziel 24,63
Veränderung
Endet am 21.11.24

Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $27.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,47 %
Kursziel 29,43
Veränderung
Endet am 18.03.25

Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 17,20 %
Kursziel 16,12
Veränderung
Endet am 19.03.25

Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Ratings data for VSTM provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,93 %
Kursziel 16,20
Veränderung
Endet am 13.05.25

Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Ratings data for VSTM provided by MarketBeat